GA
AMGN icon

Greytown Advisors’s Amgen AMGN Stock Holding History

Greytown Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,260
Closed -$305K – 102
2022
Q1 		$305K Sell
1,260
-1,607
-56% -$369K 0.15% 86
2021
Q4 		$645K Buy
2,867
+774
+37% +$163K 0.27% 59
2021
Q3 		$445K Buy
+2,093
New +$482K 0.2% 76

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Greytown Advisors's AMGN Position: Q2 2022 in Review

Greytown Advisors sold out of Amgen (AMGN) in Q2 2022, closing a stake of 1,260 shares — an estimated $305K sold.

Greytown Advisors first reported a position in AMGN in Q3 2021 and held it in 3 quarters. The position peaked at $645K in Q4 2021. 2,352 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

  • Greytown Advisors reported no remaining Amgen position as of Q2 2022 after selling out during the quarter.
  • Greytown Advisors sold 1,260 Amgen shares in Q2 2022, an estimated $305K.
  • Greytown Advisors first reported a position in Amgen in Q3 2021 and held it in 3 quarters.
  • Greytown Advisors's Amgen position peaked at $645K in Q4 2021.
  • 2,352 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on Greytown Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.